Grozone is a JOINT venture between AMFE and A.C.T.S.
There is also a JOINT venture between AMFE and RGI (Rotogro International)
So, the question is what percent of Grozone or AMFE does A.C.T.S. own....and what part of Grozone is owned by RGI. And what percent Easton Pharma owns of grozone or amfe
Amfil Technologies Inc. has entered a JVA to acquire the exclusive rights to a 50% shared ownership in the mPact -GROzone Antimicrobial Systems line of products and exclusive representation to perform with A.C.T.S. as a systems and service provider of units geared towards the Medical Marijuana Industry and other related legal marijuana growing/processing facilities in North America & Worldwide
TORONTO, ON--(Marketwired - Jul 8, 2014) - Easton Pharmaceuticals Inc. (OTC: EAPH) - announces that it has advanced funds and closed on an agreement to invest and purchase an ownership interest in AMFIL Technologies Inc. and The mPact -GROzone Antimicrobial Systems Line of Products.
[color=red]The agreement includes an option to purchase warrants allowing Easton to purchase an additional ownership interest up to 32.5% of AMFIL.[/color]
As previously announced, Easton Pharmaceuticals has advanced funding and acquired an initial ownership interest in AMFIL Technologies and its mPact - GROzone Antimicrobial System, with an option to purchase a much bigger 32.5% or more ownership interest. AMFIL's lead scientist and inventor is currently in Colorado after a GROzone unit was previously integrated into a commercially licensed, state of the art medical marijuana grow facility in Colorado.
Easton Pharmaceuticals in 2014 completed an investment into AMFIL Technologies with an option to purchase additional equity. The investment was originally used to assist AMFIL in general expenses and towards developing the GROzone technology for the medical marijuana industry. Since the initial Easton investment in July of 2014, AMFIL has made significant strides with its business.
Easton Pharmaceuticals and AMFIL Technologies are initiating discussions toward another possible investment into AMFIL Technologies by Easton pursuant to an agreement signed between Easton and AMFIL in July of 2014 and the resulting investment made into AMFIL at that time
For A.C.T.S. Inc. to grant AMFIL a 50% shared ownership with A.C.T.S. Inc. of mPact -GROzone Antimicrobial Systems and the exclusive right of representation to perform with A.C.T.S. Inc. as a Systems and Service Provider to any Medical Marijuana Industry and legal marijuana grow/process establishments or organisations in North America and globally that is amenable to the use of the Systems and Service of mPact -GROzone Antimicrobial Systems using A.C.T.S. Inc.’s trade- marked and propriety products and systems under the conditions covered in this agreement.
TORONTO, ON--(Marketwired - May 1, 2017) - Amfil Technologies, Inc. (OTC PINK: AMFE) is pleased to announce that the company has signed an agreement with Roto-Gro World Wide Inc., a wholly owned subsidiary of Roto-Gro International Ltd. (ASX: RGI) to form a joint venture to integrate and distribute the GROzone EcoPr03 Antimicrobial System with the revolutionary Roto-Gro Rotary Hydroponic systems.
The Roto-Gro automated rotary hydroponic system was designed, developed, and manufactured in Canada in 2006. The system has been recognised by several cannabis producers and distributors in Canada, Europe and the US and has an established client base, including Canadian based Nutrilife Products, being one of its largest customers with sales to the group already exceeding 600 units. They have also recently entered into an agreement with EuroAg Corporation for the supply of 240 Roto-Gro Units over a 12-month period. The company recently debuted on the Australian Stock Exchange through IPO in February 2017.
Market Data 
Markets 
AI
